MariuszAndrzeWasikMD
Pathology • Philadelphia, PAHematopathology, Anatomic Pathology, Clinical Pathology
Professor, Pathology & Laboratory Medicine, Perelman School of Medicine
Dr. Wasik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Ave
Philadelphia, PA 19111Phone+1 215-728-3675Fax+1 215-728-2848
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematopathology, 1992 - 1993
Boston University Medical CenterResidency, Pathology-Anatomic and Clinical, 1988 - 1991
Wroclaw Medical UniversityClass of 1979
Certifications & Licensure
PA State Medical License 1993 - 2024- American Board of Pathology Anatomic Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- Impact of therapeutic inhibition of oncogenic cell signaling tyrosine kinase on cell metabolism: in vivo-detectable metabolic biomarkers of inhibition.Kavindra Nath, Pradeep K Gupta, Johnvesly Basappa, Shengchun Wang, Neil Sen
Journal of Translational Medicine. 2024-07-04 - Genomic Evolution of Oligometastatic Clear Cell Renal Cell Carcinoma Presenting Two Decades Following Radical Nephrectomy.Robert Wang, Nicole Uzzo, Raju Chelluri, Nicholas Mackrides, Hormoz Ehya
Urology. 2024-02-01 - 1 citationsDiverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implications.Mariusz A Wasik, Patricia M Kim, Reza Nejati
Frontiers in Oncology. 2024-01-01
Journal Articles
- LRPAP1 Is a Frequent Proliferation-Inducing Antigen of BCRs of Mantle Cell Lymphomas and Can Be Used for Specific Therapeutic TargetingStephen J Schuster, Mariusz Wasik, Nature
Press Mentions
Mariusz Wasik Joins Fox Chase Cancer Center as Chair of PathologyMay 23rd, 2018
Grant Support
- Novel Role Of STAT3 In Npm/Alk-Induced OncogenesisNational Cancer Institute2009–2012
- JAK/STAT Signaling In Human T-Cell LymphomasNational Cancer Institute2006–2010
- (M) TOR Signaling In Ebv-Associated LymphomasNational Institute Of Dental &Craniofacial Research2005–2007
- Dysregulation Of STAT3 In Alk-Induced OncogenesisNational Cancer Institute2002–2006
- Aberrant JAK/STAT Signaling In Cutaneous T Cell LymphomaNational Cancer Institute2001–2005
- IL 2R Signaling Pathways In T Cell LymphomaNational Cancer Institute1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
